전체메뉴
검색
Article Search

JMB Journal of Microbiolog and Biotechnology

QR Code QR Code

Research article

References

  1. Sassu EL, Bossé JT, Tobias TJ, Gottschalk M, Langford PR, Hennig-Pauka I. 2018. Update on Actinobacillus pleuropneumoniae− knowledge, gaps and challenges. Transbound. Emerg. Dis. 65 Suppl 1: 72-90.
    Pubmed
  2. Liu J, Chen X, Lin L, Tan C, Chen Y, Guo Y, et al. 2007. Potential use an Actinobacillus pleuropneumoniae double mutant strain ΔapxIICΔapxIVA as live vaccine that allows serological differentiation between vaccinated and infected animals. Vaccine 25: 76967705.
    Pubmed
  3. Mei L, Zhou R, Lu HS, Bei WC, Liu WH, Lin LW, et al. 2006. Study on the immunogenicity of N-terminal polypeptide of RTX toxin I of Actinobacillus pleuropneumoniae. Chin. J. Biotechnol. 22: 39-45.
  4. Bossé JT, Li Y, Sárközi R, Fodor L, Lacouture S, Gottschalk M, et al. 2018. Proposal of serovars 17 and 18 of Actinobacillus pleuropneumoniae based on serological and genotypic analysis. Vet. Microbiol. 217: 1-6.
    Pubmed PMC
  5. Ramjeet M, Deslandes V, Gouré J, Jacques M. 2008. Actinobacillus pleuropneumoniae vaccines: from bacterins to new insights into vaccination strategies. Anim. Health. Res. Rev. 9: 25-45.
    Pubmed
  6. Frey J. 1995. Virulence in Actinobacillus pleuropneumoniae and RTX toxins. Trends Microbiol. 3: 257-261.
  7. Bossé JT, Janson H, Sheehan BJ, Beddek AJ, Rycroft AN, Kroll JS, et al. 2002. Actinobacillus pleuropneumoniae: pathobiology and pathogenesis of infection. Microbes Infect. 4: 225-235.
  8. Chiers K, De Waele T, Pasmans F, Ducatelle R, Haesebrouck F. 2010. Virulence factors of Actinobacillus pleuropneumoniae involved in colonization, persistence and induction of lesions in its porcine host. Vet. Res. 41: 65.
    Pubmed PMC
  9. Del Pozo Sacristán R, Michiels A, Martens M, Haesebrouck F, Maes D. 2014. Efficacy of vaccination against Actinobacillus pleuropneumoniae in two Belgian farrow-to-finish pig herds with a history of chronic pleurisy. Vet. Rec. 174: 302.
    Pubmed
  10. Schaller A, Djordjevic SP, Eamens GJ, Forbes WA, Kuhn R, Kuhnert P, et al. 2001. Identification and detection of Actinobacillus pleuropneumoniae by PCR based on the gene apxIVA. Vet. Microbiol. 79: 47-62.
  11. Schuchert JA, Inzana TJ, Angen O, Jessing S. 2004. Detection and identification of Actinobacillus pleuropneumoniae serotypes 1, 2, and 8 by multiplex PCR. J. Clin. Microbiol. 42: 4344-4348.
    Pubmed PMC
  12. Angen O, Ahrens P, Jessing SG. 2008. Development of a multiplex PCR test for identification of Actinobacillus pleuropneumoniae serovars 1, 7, and 12. Vet. Microbiol. 132: 312-318.
    Pubmed
  13. Lo TM, Ward CK, Inzana TJ. 1998. Detection and identification of Actinobacillus pleuropneumoniae serotype 5 by multiplex PCR. J. Clin. Microbiol. 36: 1704-1710.
    Pubmed PMC
  14. Frey J, Nicolet J. 1988. Regulation of hemolysin expression in Actinobacillus pleuropneumoniae serotype 1 by Ca2+. Infect. Immun. 56: 2570-2575.
    Pubmed PMC
  15. Nielsen R, van den Bosch JF, Plambeck T, Sorensen V, Nielsen JP. 2000. Evaluation of an indirect enzyme-linked immunosorbent assay (ELISA) for detection of antibodies to the Apx toxins of Actinobacillus pleuropneumoniae. Vet. Microbiol. 71: 81-87.
  16. Van Den Bosch JF (Boxmeer, NL). 1997. Actinobacillus pleuropneumoniae subunit vaccine. United States patent application 5648081.
  17. Wu HC, Yeh PH, Hsueh KJ, Yang WJ, Chu CY. 2018. Recombinant ApxIV protein enhances protective efficacy against Actinobacillus pleuropneumoniae in mice and pigs. J. Appl. Microbiol. 124: 1366-1376.
    Pubmed
  18. Haga Y, Ogino S, Ohashi S, Ajito T, Hashimoto K, Sawada T. 1997. Protective efficacy of an affinity-purified hemolysin vaccine against experimental swine pleuropneumonia. J. Vet. Med. Sci. 59: 115-120.
    Pubmed
  19. Frey J, Nicolet J. 1988. Purification and partial characterization of a hemolysin produced by Actinobacillus pleuropneumoniae type strain 4074. FEMS Microbiol. Lett. 55: 41-45.
  20. Lee KE, Choi HW, Kim HH, Song JY, Yang DK. 2015. Prevalence and characterization of Actinobacillus pleuropneumoniae isolated from Korean pigs. J. Bacteriol. Virol. 45: 19-25.
  21. Komal JP, Mittal KR. 1990. Grouping of Actinobacillus pleuropneumoniae strains of serotypes 1 through 12 on the basis of their virulence in mice. Vet. Microbiol. 25: 229-240.
  22. Yuan F, Liu J, Guo Y, Tan C, Fu S, Zhao J, et al. 2011. Influences of ORF1 on the virulence and immunogenicity of Actinobacillus pleuropneumoniae. Curr. Microbiol. 63: 574-580.
    Pubmed
  23. Šatrán P, Nedbalcová K, Kučerová Z. 2003. Comparison of protection efficacy of toxoid and whole-cell vaccines against porcine pleuropneumonia caused by endotracheal infection with Actinobacillus pleuropneumoniae. Acta Vet. Brno 72: 213-219.
  24. Liao CW, Chiou HY, Yeh KS, Chen JR, Weng CN. 2003. Oral immunization using formalin-inactivated Actinobacillus pleuropneumoniae antigens entrapped in microspheres with aqueous dispersion polymers prepared using a co-spray drying process. Prev. Vet. Med. 61: 1-15.
  25. Huter V, Hensel A, Brand E, Lubitz W. 2000. Improved protection against lung colonization by Actinobacillus pleuropneumoniae ghosts: characterization of a genetically inactivated vaccine. J. Biotechnol. 83: 161-172.
  26. Jarma E, Regassa LB. 2004. Growth phase mediated regulation of the Actinobacillus pleuropneumoniae ApxI and ApxII toxins. Microb. Pathog. 36: 197-203.
    Pubmed
  27. Hensel A, Stockhofe-Zurwieden N, Petzoldt K, Lubitz W. 1995. Oral immunization of pigs with viable or inactivated Actinobacillus pleuropneumoniae serotype 9 induces pulmonary and systemic antibodies and protects against homologous aerosol challenge. Infect. Immun. 63: 3048-3053.
    Pubmed PMC
  28. Crespo AL, Spencer TA, Nekl E, Pusztai-Carey M, Moar WJ, Siegfried BD. 2008. Comparison and validation of methods to quantify Cry1Ab toxin from Bacillus thuringiensis for standardization of insect bioassays. Appl. Environ. Microbiol. 74: 130-135.
    Pubmed PMC
  29. Knight MI, Chambers PJ. 2003. Problems associated with determining protein concentration: a comparison of techniques for protein estimations. Mol. Biotechnol. 23: 19-28.
  30. Phonvisay M, Lee JW, Liou JJ, Wang HY, Chu CY. 2019. Evaluation of long-term antibody response and cross-serotype reaction in ducks immunised with recombinant Riemerella anatipestifer outer membrane protein A and CpG ODN. J. Vet. Res. 63: 543-548.
    Pubmed PMC
  31. Dao HT, Truong QL, Do VT, Hahn TW. 2020. Construction and immunization with double mutant ΔapxIBD Δpnp forms of Actinobacillus pleuropneumoniae serotypes 1 and 5. J. Vet. Sci. 21: e20.
    Pubmed PMC
  32. Lin L, Bei W, Sha Y, Liu J, Guo Y, Liu W, et al. 2007. Construction and immunogencity of a ΔapxIC/ΔapxIIC double mutant of Actinobacillus pleuropneumoniae serovar 1. FEMS Microbiol. Lett. 274: 55-62.
    Pubmed
  33. Frey J. 2011. The role of RTX toxins in host specificity of animal pathogenic Pasteurellaceae. Vet. Microbiol. 153: 51-58.
    Pubmed